Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler.
Launched in 2016, the web- and mobile-based RespiPoints program offers patients a variety of adherence-...
Around the world, pharmaceutical companies are losing $637 billion in revenue per year from a multifaceted, but common problem: people with chronic conditions are not adhering to their medication.
In a research paper by medication adherence company HealthPrize Technologies and consulting company Capgemini, the issue was described as “one of the most serious problems in healthcare,” affecting all...
Digital patient engagement company HealthPrize Technologies has partnered with Walgreens to offer its medication adherence platform on the drugstore chain’s website. The program will be offered to patients filling certain brand-name prescriptions for chronic conditions, starting with diabetes and eventually expanding to others. The platform will be web-based, but Walgreen's site is optimized for...
